Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Advanced Materials (Deerfield Beach, Fla.)|January 8, 2024
Restructuring Electrolyte Solvation by a Versatile Diluent Toward Beyond 99.9% Coulombic Efficiency of Sodium Plating/Stripping at Ultralow TemperaturesLiang Hu, Jiaojiao Deng, Yuxiao Lin, et al.
ACS Macro Letters|November 4, 2025
Synergistic PEDOT:SBCD Electrochemical Platform for Simultaneous Detection of Multiple Metabolic Biomarkers in Human UrineYu Zhang, Jia Guo, Zuhang Ding, et al.
Apoptosis : an International Journal on Programmed Cell Death|May 18, 2020
Doxorubicin sensitizes cancer cells to Smac mimetic via synergistic activation of the CYLD/RIPK1/FADD/caspase-8-dependent apoptosisChengkui Yang, Qiao Ran, Yifei Zhou, et al.
Angewandte Chemie (International Ed. in English)|March 19, 2026
Accessing Four-Sodium Storage in NaxV2(PO4)3 (1≤x≤5) Cathodes via Precise Chemical Pre-Sodiation Toward High-Energy and Long-Life Anode-Free Sodium BatteriesMingli Xu, Tingcan Li, Zu Chang, et al.
Journal of Virology|November 13, 2015
Herpes Simplex Virus 1 (HSV-1) and HSV-2 Mediate Species-Specific Modulations of Programmed Necrosis through the Viral Ribonucleotide Reductase Large Subunit R1Xiaoliang Yu, Yun Li, Qin Chen, et al.
Biochemical Pharmacology|June 14, 2023
Discovery of a novel RIPK2 inhibitor for the treatment of inflammatory bowel diseaseYujun Lai, Xinhui Wang, Xue Sun, et al.
Cell Death Discovery|February 23, 2026
A viable kinase-inactive RIPK3 D143N mouse model reveals its scaffold function in driving TNF-induced inflammatory disorderYayun Du, Jingjing Li, Cong Zhao, et al.
EMBO Reports|June 23, 2022
Interferon-mediated repression of miR-324-5p potentiates necroptosis to facilitate antiviral defenseXiaoyan Dou, Xiaoliang Yu, Shujing Du, et al.
Frontiers in Cell and Developmental Biology|December 28, 2020
Discovery of a Potent RIPK3 Inhibitor for the Amelioration of Necroptosis-Associated Inflammatory InjuryKaijiang Xia, Fang Zhu, Chengkui Yang, et al.
Cell Death & Disease|June 26, 2019
Discovery of potent necroptosis inhibitors targeting RIPK1 kinase activity for the treatment of inflammatory disorder and cancer metastasisJue Hou, Jie Ju, Zili Zhang, et al.
Pageof 5